Good Lifestyle

Sunday, President Donald Trump and FDA have made a major announcement issuing an emergency authorization for convalescence plasma as a CVIV-19 treatment method. By the organization, the convalescence plasma "can be effective in the treatment of COVID-19 and that the known and potential benefits of the product outweigh the known and potential risks of the product". They even cited statistics that the use of convalescent plasma reduced the deaths of 35%. However, there is some controversy as to the promising treatment, and according to a yale hematologist, more research is needed to fully understand its effect. Read it, and stay safe and stay safe during this pandemic, do not miss this essential list ofWithout signs that you have already had coronavirus.

The truth is: "We need greater clinical studies"

Sabrina Browning, MD, a hematologist of Yale medicine, explains toEat this, not that! Health This convalescent plasma is a blood component collected from people who have already been recovered from an infection. "It is believed that this blood component contains antibodies created by the immune system to combat a specific infection," she says.

Once the blood is collected, it is given via a blood transfusion to those with a current or continuous infection, in order to transfer these antibodies so that the body can use them to combat infection.

Treatment has been used for various infections over the last century and has recently been used for CVIV-19 management. However, Dr. Browning is not fully convinced that it is a miracle treatment for the virus, like research, simply, is not there.

"Although this suggests that this treatment is safe and effective for those who suffer from COVID-19, which is encouraging, we really need higher randomized clinical studies so that some people receive a convalescent plasma and that D others receive a placebo, in order to understand its full effect, "she explains.

'It seems to be safe'

It also emphasizes that the importance of measuring the amount of antibodies in convalescent plasma given to patients to better understand how useful it could be. For example, how patients who receive less antibodies meet compared to those who receive more. In addition, she points out that there seems to be a better answer when the convalescent plasma is given earlier in a person's disease.

Although the more must be revealed, it supports its use - especially at this stage of the pandemic when we need it most. "With all that being said, convalescent plasma transfusion seems to be safe and this therapy has completed an immediate need during an unimaginably stimulating public health crisis," she continues. "However, it is important that we are now continuing to study its use in randomized clinical trials to confirm its advantage." As for yourself: go through this pandemic at your healthier, do not miss these37 places you are most likely to catch coronavirus.